SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-143627
Filing Date
2023-05-12
Accepted
2023-05-12 17:15:18
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d444331ds3.htm S-3 412400
2 EX-4.3 d444331dex43.htm EX-4.3 286134
3 EX-4.5 d444331dex45.htm EX-4.5 96407
4 EX-4.6 d444331dex46.htm EX-4.6 98690
5 EX-4.7 d444331dex47.htm EX-4.7 89109
6 EX-5.1 d444331dex51.htm EX-5.1 28201
7 EX-23.1 d444331dex231.htm EX-23.1 1661
8 EX-FILING FEES d444331dexfilingfees.htm EX-FILING FEES 73625
9 GRAPHIC g444331dsp154.jpg GRAPHIC 3998
10 GRAPHIC g444331g40a40.jpg GRAPHIC 69302
11 GRAPHIC g444331g89a89.jpg GRAPHIC 72399
  Complete submission text file 0001193125-23-143627.txt   1288386
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271902 | Film No.: 23917005
SIC: 2834 Pharmaceutical Preparations